Assuntos
Abscesso , Gonorreia/complicações , Uretrite/complicações , Abscesso/diagnóstico por imagem , Abscesso/etiologia , Abscesso/cirurgia , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Seguimentos , Gonorreia/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Neisseria gonorrhoeae/genética , Neisseria gonorrhoeae/crescimento & desenvolvimento , Resultado do Tratamento , Ultrassonografia , Uretrite/tratamento farmacológicoRESUMO
Rising renal cell carcinoma incidence is in relationship with early diagnosis during radiological exams. Radical nephrectomy was the gold standard treatment for 30 years. Partial nephrectomy is nowadays a validated therapeutic option for renal cell carcinoma up to 7 cm with comparable oncological results associated with better life quality and survival. Partial nephrectomy is tricky and laparoscopic approach remains reserved for expert centers.
Assuntos
Carcinoma de Células Renais/cirurgia , Neoplasias Renais/cirurgia , Nefrectomia/métodos , Carcinoma de Células Renais/diagnóstico por imagem , Humanos , Qualidade de Vida , Sobreviventes , Tomografia Computadorizada por Raios XRESUMO
This reviewed publication summarized the newly therapeutic procedures in different urological pathologies. In the treatment of benign prostate hyperplasia (BPH), laser KTP with high power is now becoming a standard. For small benign testicle lesions, the surgical biopsy under echographic control avoid radical orchidectomy. In non-invasive bladder cancer, Hexvix fluorescence is gaining a wide acceptance. In invasive bladder cancer, new protocols of neoadjuvant chemotherapy demonstrate an increased interest. In renal cancer, immunomodulation and angiogenesis molecules seem to offer some hopes for advanced tumors. In bladder dysfunctions such as hyperactive bladder, new molecules have widens the range of the available treatments.